Crossref
Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn
Clinical Laboratory · 2026 · 72 (06/2026)
DOI: 10.7754/clin.lab.2025.250767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Xueni Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Erythroblastosis, FetalHumansFemalePregnancyInfant, NewbornRetrospective StudiesAdultSeverity of Illness IndexIsoantibodies
Substanzen
Isoantibodies
Zitieren
APA
Chen, X., Jiang, A., Yu, Y., & Chen, Y. (2026). Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn. Clinical Laboratory, 72(06/2026). https://doi.org/10.7754/clin.lab.2025.250767
Vancouver
Chen X, Jiang A, Yu Y, Chen Y. Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn. Clinical Laboratory. 2026;72(06/2026). doi:10.7754/clin.lab.2025.250767
BibTeX
@article{Chen2026,
author = {Chen, Xueni and Jiang, Aihong and Yu, Yajuan and Chen, Yulin},
title = {Correlation between Maternal Anti-E Antibody Titer and the Severity of Hemolytic Disease of the Fetus and Newborn},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {06/2026},
doi = {10.7754/clin.lab.2025.250767}
}
EUVIMED